76157-13-6Relevant articles and documents
A two-steps benzotriazole-assisted synthesis of 3-amino-2-ethoxycarbonyl imidazo [1,2-a] pyridines and related compounds
Moutou, Jean-Luc,Schmitt, Martine,Collot, Valerie,Bourguignon, Jean-Jacques
, p. 1787 - 1790 (1996)
Reaction of primary heterocyclic amidines with benzotriazole and ethyl glyoxylate or ethyl glyoxylate equivalents afforded the corresponding α-benzotriazolyl-α-amidino esters which, upon treatment potassium cyanide yielded the corresponding 3-amino-2-ethoxycarbonyl imidazo [1,2-a] pyridines and related compounds.
Microwave-Assisted Suzuki–Miyaura and Sonogashira Coupling of 4-Chloro-2-(trifluoromethyl)pyrido[1,2-e]purine Derivatives
Tber, Zahira,Biteau, Nicolas G.,Agrofoglio, Luigi,Cros, Julien,Goffinont, Stéphane,Castaing, Bertrand,Nicolas, Cyril,Roy, Vincent
, p. 5756 - 5767 (2019/08/20)
The convenient preparation of three imidazo[1,2-a]pyridine-2-carboxamide intermediates is reported through known Strecker–Ugi type multicomponent reactions, Tschitschibabin type condensations, and further synthetic sequences. The derivatives were then efficiently converted to novel 4-chloro-2-(trifluoromethyl)pyrido[1,2-e]purines by their original reactions with 2,2,2-trifluoroacetamide, followed by subsequent dehydroxychlorination reactions. These compounds were cross-coupled under microwave irradiation through SuzukiMiyaura and Sonogashira palladium(0) catalysis to various aromatic and alkynyl reagents, thus providing the related C-4 substituted pyrido[1,2-e]purines of biological interest in good yields.
BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS
-
Page/Page column 155, (2017/02/09)
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Desilylative activation of TMSCN in chemoselective Strecker-Ugi type reaction: Functional fused imidazoles as building blocks as an entry route to annulated purines
Guchhait, Sankar K.,Chaudhary, Vikas
, p. 6694 - 6705 (2014/08/18)
A pathway of desilylative activation of TMSCN as a functional isonitrile equivalent, and DABCO-THF as an appropriate system for activation in a chemoselective Strecker-Ugi type reaction, has rendered ethyl glyoxalate and various heterocyclic-2-amidines as feasible substrates, and afforded the successful synthesis of 3-amino-2-carboxyethyl substituted fused imidazoles as useful building blocks. This class of functional scaffold has provided, via construction of the fused pyrimidinone motif, the synthesis of biologically important C8-N9 annulated purines, adenines and their oxo/thio analogs. This new approach is convenient and flexible for the preparation of versatile purine-condensed heterocycles. This journal is the Partner Organisations 2014.